Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

1.

JNCI and cancer prevention.

Dunn BK, Ghosh S, Kramer BS.

J Natl Cancer Inst. 2015 Feb 24;107(3). pii: djv021. doi: 10.1093/jnci/djv021. Print 2015 Mar.

PMID:
25713150
3.

Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM Jr, Blanke CD, Klein EA.

JAMA Ophthalmol. 2015 Jan;133(1):17-24. doi: 10.1001/jamaophthalmol.2014.3478.

PMID:
25232809
4.

Selenium and vitamin E raise risk of prostate cancer.

[No authors listed]

Harv Mens Health Watch. 2014 May;18(10):8. No abstract available.

PMID:
25108949
5.

Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model.

Singh CK, Ndiaye MA, Siddiqui IA, Nihal M, Havighurst T, Kim K, Zhong W, Mukhtar H, Ahmad N.

Oncotarget. 2014 Jun 15;5(11):3651-61.

6.

Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?

Liang Y, Ketchum NS, Goodman PJ, Klein EA, Thompson IM Jr.

J Urol. 2014 Oct;192(4):1094-9. doi: 10.1016/j.juro.2014.04.015. Epub 2014 Apr 18.

7.

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA.

J Natl Cancer Inst. 2014 Mar;106(3):djt456. doi: 10.1093/jnci/djt456. Epub 2014 Feb 22.

8.

Future directions in the prevention of prostate cancer.

Thompson IM Jr, Cabang AB, Wargovich MJ.

Nat Rev Clin Oncol. 2014 Jan;11(1):49-60. doi: 10.1038/nrclinonc.2013.211. Epub 2013 Nov 26. Review.

PMID:
24281061
9.

Chemoprevention of prostate cancer.

Vemana G, Hamilton RJ, Andriole GL, Freedland SJ.

Annu Rev Med. 2014;65:111-23. doi: 10.1146/annurev-med-121211-091759. Epub 2013 Nov 4. Review.

PMID:
24188663
10.

Dietary antioxidants and prostate cancer: a review.

Vance TM, Su J, Fontham ET, Koo SI, Chun OK.

Nutr Cancer. 2013;65(6):793-801. doi: 10.1080/01635581.2013.806672. Review.

11.

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR.

J Natl Cancer Inst. 2013 Aug 7;105(15):1132-41. doi: 10.1093/jnci/djt174. Epub 2013 Jul 10.

12.

Prostate cancer chemoprevention.

Sandhu GS, Nepple KG, Tanagho YS, Andriole GL.

Semin Oncol. 2013 Jun;40(3):276-85. doi: 10.1053/j.seminoncol.2013.04.003. Review.

PMID:
23806493
13.

Review of selenium and prostate cancer prevention.

Yang L, Pascal M, Wu XH.

Asian Pac J Cancer Prev. 2013;14(4):2181-4. Review.

14.

Advances in prostate cancer chemoprevention: a translational perspective.

Nambiar D, Singh RP.

Nutr Cancer. 2013;65 Suppl 1:12-25. doi: 10.1080/01635581.2013.785006. Review.

PMID:
23682779
15.

[Pharmaco and diet based prostate cancer prevention].

Eisinger F, Cancel-Tassin G, Azzouzi AR, Gravis G, Rossi D, Cussenot O.

Bull Cancer. 2013 May;100(5):497-507. doi: 10.1684/bdc.2013.1739. Review. French.

PMID:
23694994
16.

Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics.

Paschos A, Pandya R, Duivenvoorden WC, Pinthus JH.

Prostate Cancer Prostatic Dis. 2013 Sep;16(3):217-25. doi: 10.1038/pcan.2013.13. Epub 2013 May 14. Review.

PMID:
23670256
17.

Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT).

Nicastro HL, Dunn BK.

Nutrients. 2013 Apr 3;5(4):1122-48. doi: 10.3390/nu5041122. Review.

18.

Prostate cancer prevention: strategies for agent development.

Parnes HL, House MG, Tangrea JA.

Curr Opin Oncol. 2013 May;25(3):242-51. doi: 10.1097/CCO.0b013e32835fc8d4. Review.

PMID:
23518594
19.
20.

Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.

Waters DJ, Shen S, Kengeri SS, Chiang EC, Combs GF Jr, Morris JS, Bostwick DG.

Nutrients. 2012 Nov 6;4(11):1650-63. doi: 10.3390/nu4111650.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk